Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
Exp Cell Res
    April 2024
  1. SHOME R, Sen P, Sarkar S, Ghosh SS, et al
    Single-cell transcriptomics reveals the intra-tumoral heterogeneity and SQSTM1/P62 and Wnt/beta-catenin mediated epithelial to mesenchymal transition and stemness of triple-negative breast cancer.
    Exp Cell Res. 2024 Apr 5:114032. doi: 10.1016/j.yexcr.2024.114032.
    >> Share

    February 2024
  2. SHI X, Sun Y, Zhang Y, Wang W, et al
    Corrigendum to "MEX3A promotes development and progression of breast cancer through regulation of PIK3CA" [Exp. Cell Res. 2021 Jul 1;404(1):112580. Epub 2021 Apr 1.].
    Exp Cell Res. 2024;436:113964.
    >> Share

  3. LI Y, Wei D, Chen Z, Chen Y, et al
    RBM10 regulates the tumorigenic potential of human cancer cells by modulating PPM1B and YBX1 activities.
    Exp Cell Res. 2024;435:113932.
    >> Share

  4. XU W, Goreczny GJ, Forsythe I, Brennan G, et al
    Hic-5 regulates extracellular matrix-associated gene expression and cytokine secretion in cancer associated fibroblasts.
    Exp Cell Res. 2024;435:113930.
    >> Share

    December 2023
  5. XU WH, Zhang T, Zhou Y, Mao Y, et al
    Fluvastatin prevents lung metastasis in triple-negative breast cancer by triggering autophagy via the RhoB/PI3K/mTOR pathway.
    Exp Cell Res. 2023 Dec 18:113893. doi: 10.1016/j.yexcr.2023.113893.
    >> Share

    November 2023
  6. MA X, Wan R, Wen Y, Liu T, et al
    Deubiquitinating enzyme OTUD4 regulates metastasis in triple-negative breast cancer by stabilizing Snail1.
    Exp Cell Res. 2023 Nov 29:113864. doi: 10.1016/j.yexcr.2023.113864.
    >> Share

  7. MONTEIRO M, Zhang X, Yee D
    Insulin promotes growth in breast cancer cells through the type I IGF receptor in insulin receptor deficient cells.
    Exp Cell Res. 2023 Nov 28:113862. doi: 10.1016/j.yexcr.2023.113862.
    >> Share

    October 2023
  8. WANG C, Zhao X, Zhao L, Wang Y, et al
    PKCzeta phosphorylates VASP to mediate chemotaxis in breast cancer cells.
    Exp Cell Res. 2023 Oct 25:113823. doi: 10.1016/j.yexcr.2023.113823.
    >> Share

  9. TULUHONG D, Gao H, Li X, Wang L, et al
    Squalene epoxidase promotes breast cancer progression by regulating CCNB1 protein stability.
    Exp Cell Res. 2023 Oct 13:113805. doi: 10.1016/j.yexcr.2023.113805.
    >> Share

  10. LIU D, Guo Y, Du Q, Zhu Y, et al
    RING induces cell cycle arrest and apoptosis in human breast cancer cells by regulating the HSF1/MT2A axis.
    Exp Cell Res. 2023 Oct 3:113795. doi: 10.1016/j.yexcr.2023.113795.
    >> Share

    September 2023
  11. JING L, Zhou K, Wang Z, Li Y, et al
    YTHDF1 shapes "cold" tumor and inhibits CD8(+) T cells infiltration and function in breast cancer.
    Exp Cell Res. 2023;432:113778.
    >> Share

    August 2023
  12. ZHOU X, Guo X, Han J, Wang M, et al
    Cytochrome b561 regulates iron metabolism by activating the Akt/mTOR pathway to promote Breast Cancer Cells proliferation.
    Exp Cell Res. 2023 Aug 25:113760. doi: 10.1016/j.yexcr.2023.113760.
    >> Share

  13. WANG R, Gou Y, Tang M, Wang K, et al
    A mutator-derived prognostic eRNA signature provides insight into the pathogenesis of breast cancer.
    Exp Cell Res. 2023 Aug 21:113754. doi: 10.1016/j.yexcr.2023.113754.
    >> Share

  14. HUANG X, Wu J, Wang Y, Xian Z, et al
    FOXQ1 inhibits breast cancer ferroptosis and progression via the circ_0000643/miR153/SLC7A11 axis.
    Exp Cell Res. 2023 Aug 15:113737. doi: 10.1016/j.yexcr.2023.113737.
    >> Share

    May 2023
  15. TUGRUL B, Balcan E, Oztel Z, Collu F, et al
    Prion protein-dependent regulation of p53-MDM2 crosstalk during endoplasmic reticulum stress and doxorubicin treatments might be essential for cell fate in human breast cancer cell line, MCF-7.
    Exp Cell Res. 2023;429:113656.
    >> Share

  16. TAN X, Li Y, Hou Z, Zhang M, et al
    Combination therapy with PD-1 inhibition plus rapamycin and metformin enhances anti-tumor efficacy in triple negative breast cancer.
    Exp Cell Res. 2023 May 22:113647. doi: 10.1016/j.yexcr.2023.113647.
    >> Share

  17. TSENG LM, Lau KY, Chen JL, Chu PY, et al
    Regorafenib induces damage-associated molecular patterns, cancer cell death and immune modulatory effects in a murine triple negative breast cancer model.
    Exp Cell Res. 2023 May 18:113652. doi: 10.1016/j.yexcr.2023.113652.
    >> Share

    April 2023
  18. MAHMOUD L, Cougnoux A, Bekiari C, Araceli Ruiz de Castroviejo Teba P, et al
    Microscopy-based phenotypic monitoring of MDA-MB-231 spheroids allows the evaluation of phenotype-directed therapy.
    Exp Cell Res. 2023;425:113527.
    >> Share

    March 2023
  19. CAO C, Lu X, Guo X, Zhao H, et al
    Patient-derived models: Promising tools for accelerating the clinical translation of breast cancer research findings.
    Exp Cell Res. 2023;425:113538.
    >> Share

    February 2023
  20. LIU B, Qu X, Wang J, Xu L, et al
    LINC00365 functions as a tumor suppressor by inhibiting HIF-1alpha-mediated glucose metabolism reprogramming in breast cancer.
    Exp Cell Res. 2023 Feb 15:113514. doi: 10.1016/j.yexcr.2023.113514.
    >> Share

    January 2023
  21. ZHENG R, Yu Y, Lv L, Zhang Y, et al
    m(6)A reader HNRNPA2B1 destabilization of ATG4B regulates autophagic activity, proliferation and olaparib sensitivity in breast cancer.
    Exp Cell Res. 2023 Jan 21:113487. doi: 10.1016/j.yexcr.2023.113487.
    >> Share

    October 2022
  22. JIN Y, Cai W, Zhao C, Yang F, et al
    EMT status of circulating breast cancer cells and impact of fluidic shear stress.
    Exp Cell Res. 2022 Oct 10:113385. doi: 10.1016/j.yexcr.2022.113385.
    >> Share

    September 2022
  23. WU K, Zhang H, Zhou L, Chen L, et al
    Histone deacetylase inhibitor panobinostat in combination with rapamycin confers enhanced efficacy against triple-negative breast cancer.
    Exp Cell Res. 2022 Sep 21:113362. doi: 10.1016/j.yexcr.2022.113362.
    >> Share

  24. SINHA S, Chatterjee S, Paul S, Das B, et al
    Olaparib enhances the Resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathway.
    Exp Cell Res. 2022 Sep 5:113338. doi: 10.1016/j.yexcr.2022.113338.
    >> Share

    August 2022
  25. FOURIE C, du Plessis M, Mills J, Engelbrecht AM, et al
    The effect of HIF-1alpha inhibition in breast cancer cells prior to doxorubicin treatment under conditions of normoxia and hypoxia.
    Exp Cell Res. 2022;419:113334.
    >> Share

  26. KANNO Y, Saito N, Saito R, Kosuge T, et al
    Differential DNA-binding and cofactor recruitment are possible determinants of the synthetic steroid YK11-dependent gene expression by androgen receptor in breast cancer MDA-MB 453 cells.
    Exp Cell Res. 2022;419:113333.
    >> Share

    June 2022
  27. GAO H, Li H, Wang J, Xu C, et al
    Polyamine synthesis enzyme AMD1 is closely related to the tumorigenesis and prognosis of human breast cancer.
    Exp Cell Res. 2022 Jun 4:113235. doi: 10.1016/j.yexcr.2022.113235.
    >> Share

  28. XIAO H, Long J, Chen X, Tan MD, et al
    NUPR1 promotes the proliferation and migration of breast cancer cells by activating TFE3 transcription to induce autophagy.
    Exp Cell Res. 2022 Jun 2:113234. doi: 10.1016/j.yexcr.2022.113234.
    >> Share

    May 2022
  29. UDDIN MB, Roy KR, Hill RA, Roy SC, et al
    p53 missense mutant G242A subverts natural killer cells in sheltering mouse breast cancer cells against immune rejection.
    Exp Cell Res. 2022 May 18:113210. doi: 10.1016/j.yexcr.2022.113210.
    >> Share

  30. CHEN L, Han S, Li Y, Zheng Y, et al
    SEZ6L2, regulated by USF1, accelerates the growth and metastasis of breast cancer.
    Exp Cell Res. 2022 May 3:113194. doi: 10.1016/j.yexcr.2022.113194.
    >> Share

    April 2022
  31. SHARMA M, Tollefsbol TO
    Combinatorial epigenetic mechanisms of sulforaphane, genistein and sodium butyrate in breast cancer inhibition.
    Exp Cell Res. 2022 Apr 18:113160. doi: 10.1016/j.yexcr.2022.113160.
    >> Share

  32. ZHU Q, Wan NB, Deng HW, Lu LL, et al
    SEC14L3 plays a tumor-suppressive role in breast cancer through a Wnt/beta-catenin-related way.
    Exp Cell Res. 2022 Apr 18:113161. doi: 10.1016/j.yexcr.2022.113161.
    >> Share

  33. LI L, Gan YP, Peng H
    RAMP2-AS1 inhibits CXCL11 expression to suppress malignant phenotype of breast cancer by recruiting DNMT1 and DNMT3B.
    Exp Cell Res. 2022 Apr 4:113139. doi: 10.1016/j.yexcr.2022.113139.
    >> Share

    March 2022
  34. CHI F, Chen L, Jin X, He G, et al
    CKAP2L, transcriptionally inhibited by FOXP3, promotes breast carcinogenesis through the AKT/mTOR pathway.
    Exp Cell Res. 2022;412:113035.
    >> Share

    February 2022
  35. JOO HJ, Chung GE, Han S, Ka HI, et al
    Adapted suspension tumor cells rewire metabolic pathways for anchorage-independent survival through AKT activation.
    Exp Cell Res. 2022;411:113005.
    >> Share

  36. DEHDARI H, Moradian F, Barzegar A, Ebrahimzadeh MA, et al
    CYP1A1 contiguous hypermethylation within a putative CpG block is associated with breast cancer progression: Feasibility to define boundary motives.
    Exp Cell Res. 2022;413:113062.
    >> Share

  37. MU H, Wang N, Zhao L, Li S, et al
    Corrigendum to "Methylation of PLCD1 and adenovirus-mediated PLCD1 overexpression elicits a gene therapy effect on human breast cancer" [Exp Cell Res. 2015 Mar 15; 332(2):179-89].
    Exp Cell Res. 2022;413:113047.
    >> Share

    January 2022
  38. HAN X, Long Y, Duan X, Liu Z, et al
    ZEB1 induces ROS generation through directly promoting MCT4 transcription to facilitate breast cancer.
    Exp Cell Res. 2022 Jan 27:113044. doi: 10.1016/j.yexcr.2022.113044.
    >> Share

  39. CHEUNG BCH, Hodgson L, Segall JE, Wu M, et al
    Spatial and temporal dynamics of RhoA activities of single breast tumor cells in a 3D environment revealed by a machine learning-assisted FRET technique.
    Exp Cell Res. 2022;410:112939.
    >> Share

    December 2021
  40. TAKATANI-NAKASE T, Matsui C, Hosotani M, Omura M, et al
    Hypoxia enhances motility and EMT through the Na(+)/H(+) exchanger NHE-1 in MDA-MB-231 breast cancer cells.
    Exp Cell Res. 2021 Dec 31:113006. doi: 10.1016/j.yexcr.2021.113006.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016